Up until now, studies comparing suboxone and methadone were conducted under strict medical supervision to ensure the treatments were safe. Those receiving such treatment often find this approach restrictive, and many others end up not receiving it because the requirement to be under supervision limits ease of access.
Suboxone simplifies and facilitates the use of opioid agonist treatment by allowing for home use. Researchers with the Canadian Research Initiative in Substance Misuse evaluated the effectiveness of allowing clients with prescription opioid use disorder to take suboxone doses at home compared to standard methadone treatment.